Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of American Academy of Dermatology

• Publication date

  2012-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaad.2011.10.028PMID 22794825PMCID PMC3522486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis

  2010cited by this paper
• Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.

  2009cited by this paper
• Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice.

  2006cited by this paper
• Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.

  2003cited by this paper

• The Carcinogenesis of the Human Scalp: An Immunometabolic-Centered View

  2024cites this paper
• Topical and Intralesional Treatments for Skin Metastases and Locoregionally Advanced Melanoma

  2024cites this paper
• Indolium 1 Exerts Activity against Vemurafenib-Resistant Melanoma In Vivo

  2022cites this paper
• Gentian violet induces apoptosis and ferroptosis via modulating p53 and MDM2 in hepatocellular carcinoma.

  2022cites this paper
• Early tangential excision with guidance of gentian violate application

  2021cites this paper
• Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab

  2020cites this paper
• New Spirocyclic Hydroxamic Acids as Effective Antiproliferative Agents.

  2020cites this paper
• The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature

  2020cites this paper
• Orabase-formulated Gentian Violet Effectively Improved Oral Potentially Malignant Disorder in vitro and in vivo.

  2019cites this paper
• Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• Analysis of the Effect of Gentian Violet on Apoptosis and Proliferation in Cutaneous T-Cell Lymphoma in an In Vitro Study

  2018cites this paper
• Selenium unmasks protective iron armor: A possible defense against cutaneous inflammation and cancer.

  2018cites this paper
• Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial

  2018cites this paper
• Targeting the duality of cancer

  2017cites this paper
• Immunotolerant indoleamine‐2,3‐dioxygenase is increased in condyloma acuminata

  2017cites this paper
• Immunotolerant indoleamine-2 , 3-dioxygenase increases in condyloma acuminata Running title : Increased IDO in condyloma acuminata

  2017cites this paper
• Redox Regulation of Inflammatory Processes Is Enzymatically Controlled

  2017cites this paper
• Making cancer visible--Dyes in surgical oncology.

  2016cites this paper
• Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival.

  2016cites this paper
• Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency.

  2016cites this paper
• Toll-like receptors and cutaneous melanoma.

  2016cites this paper
• Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice

  2016cites this paper
• Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

  2016cites this paper
• VEGF-B promotes cancer metastasis through a VEGF-A–independent mechanism and serves as a marker of poor prognosis for cancer patients

  2015cites this paper
• Treatment of In-Transit Melanoma With Intralesional Bacillus Calmette-Guérin (BCG) and Topical Imiquimod 5% Cream: A Report of 3 Cases

  2015cites this paper
• Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development.

  2015cites this paper
• Redox-modulating agents target NOX2-dependent IKKε oncogenic kinase expression and proliferation in human breast cancer cell lines

  2015cites this paper
• Updates of reactive oxygen species in melanoma etiology and progression.

  2014cites this paper
• Novel Mechanism of Macrophage-Mediated MetastasisRevealed inaZebrafishModelofTumor Development

  2014cites this paper
• [In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].

  2014cites this paper
• Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells

  2014cites this paper
• Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish 1 model of tumor development 2 3 4 5

  2014cites this paper
• The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.

  2014cites this paper
• PHIPing out: a genetic basis for tumor ulceration.

  2014cites this paper
• Gentian violet induces wtp53 transactivation in cancer cells

  2014cites this paper
• Métastases en transit du mélanome : efficacité de l’imiquimod topique combiné au laser CO2 ou à l’électrocoagulation

  2014cites this paper
• Gentian Violet: a 19th century drug re‐emerges in the 21st century

  2013cites this paper
• Current Management of Malignant Melanoma: State of the Art

  2013cites this paper